Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM Growth Gross Margin Expanded 710 Basis Points Year-over-Year ...
Returned to Profitability with Net Income of $0.2M Third Consecutive Quarter of Positive Adjusted EBITDA Revenue Rises to $5.9M, with AI ...
Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12, 2025 (GLOBE ...
MIGDAL HAEMEK, Israel, Nov. 10, 2025 /PRNewswire/ -- Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT), today announced its financial ...
Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM GrowthGross Margin Expanded 710 Basis Points Year-over-YearRecent Public Offerings and Debt Restructuring Significantly ...
Mattr Corp. ("Mattr" or the "Company") (TSX: MATR) reported today its operational and financial results for the three and nine months ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results